MENU
KMTS
AS OF
Feb 4, 01:53 PM (EDT)
Price
$24.82
Change
-$0.23 (-0.92%)
Capitalization
1.46B
75 days until earnings call
Intraday BUY SELL Signals
KMTS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Kestra Medical Technologies (KMTS) Ownership - Who owns Kestra Medical Technologies?

Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected... Show more

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
1.46B
P/E Ratio
N/A
Total Cash
175.42M
Projected Growth
N/A
Total Debt
44.8M
Revenue
74.26M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
3.01
Total Debt/Equity
N/A
Revenue/Share
1.84 USD as % of share price

Fundamentals

KMTS
Capitalization
1.46B
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
175M
Total Cash/Share
3.01
Total Debt
44.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.84%
Revenue
74.3M
ROE
N/A
Book Value
164M
P/B Ratio
8.90
Cash Flow
N/A
Earnings
-3.96
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
51.4M
Current Ratio
5.47
Current Revenue Per Employee
68378.79
Dividends Per Share - Security
N/A
EBITDA
-115.81M
Float
N/A
Float - Current
N/A
Gross Income Margin
50.63
Revenue To Assets
-75.40
Shares Held By Institutions
1.69B
Shares Outstanding - Current
58.3M
Total Liabilities
82.6M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-5.562
View a ticker or compare two or three
KMTS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. KMTS showed earnings on December 11, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details